Who should be treating rectal cancer in 2013?
Date
2013-07-01Type
ReviewKeyword
Rectal neoplasms; Combined modality therapy; Outcome assessment; Outcome process; SpecializationJournal Title
British Journal of Hospital MedicineVolume
74Issue
7Metadata
Show full item recordAbstract
Management of rectal cancer has advanced significantly over the last 30 years. As the complexity of treatment increases the question of superspecialization has arisen as a means of concentrating expertise and improving outcome. This article argues that this may have merit, but only for very early and very advanced tumours.Citation
Thompson C, Williams JG. Who should be treating rectal cancer in 2013? Br J Hosp Med (Lond). 2013 Jul;74(7):372-6. doi: 10.12968/hmed.2013.74.7.372. PMID: 24159636.Rights
Attribution-NonCommercial-NoDerivs 3.0 United StatesThe following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States